Evercore ISI lowered the firm’s price target on Healthpeak Properties (DOC) to $22 from $23 and keeps an Outperform rating on the shares. In a broad REIT note, the analyst rolled forward models to incorporate the firm’s 2027 AFFO estimates into its price target framework.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak upgraded to Outperform from Market Perform at Raymond James
- Healthpeak Properties price target lowered to $21 from $22 at Morgan Stanley
- Deutsche downgrades Healthpeak to Hold on biotech challenges
- Healthpeak Properties downgraded to Hold from Buy at Deutsche Bank
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 18, 2025